Shkreli Pleads Not Guilty to Hiding Retrophin Holdings

Company founder, ex-lawyer Greebel face new conspiracy charge
Former drug company CEO accused of masking control of stock

Ex-pharmaceutical executive Martin Shkreli exits the U.S. District Court for the Eastern District of New York, on June 6, in Brooklyn.
Photographer: Drew Angerer/Getty Images

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Christie Smythe

June 6, 2016 at 5:15 PM UTC

Updated on

June 6, 2016 at 6:38 PM UTC

This article is for subscribers only.

Former drug company executive Martin Shkreli pleaded not guilty to a conspiracy charge accusing him of using employees and consultants to conceal his control of Retrophin Inc. stock.

The 33-year-old founder of Retrophin and Turing Pharmaceuticals AG entered his plea on Monday in Brooklyn federal court to the new charge in a securities fraud case.